These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 16921053

  • 21. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.
    Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446
    [Abstract] [Full Text] [Related]

  • 22. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
    Argon A, Basaran M, Yaman F, Dizdar Y, Sakar B, Camlica H, Bavbek SE, Ozger H, Darendeliler E, Onat H.
    Jpn J Clin Oncol; 2004 Nov 15; 34(11):667-72. PubMed ID: 15613556
    [Abstract] [Full Text] [Related]

  • 23. [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results].
    Paulussen M, Ahrens S, Braun-Munzinger G, Craft AW, Dockhorn-Dworniczak B, Dörffel W, Dunst J, Fröhlich B, Göbel U, Häussler M, Klingebiel T, Koscielniak E, Mittler U, Rübe C, Winkelmann W, Voûte PA, Zoubek A, Jürgens H.
    Klin Padiatr; 1999 Nov 15; 211(4):276-83. PubMed ID: 10472562
    [Abstract] [Full Text] [Related]

  • 24. Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
    Smorenburg CH, van Groeningen CJ, Meijer OW, Visser M, Boven E.
    Neth J Med; 2007 Apr 15; 65(4):132-6. PubMed ID: 17452761
    [Abstract] [Full Text] [Related]

  • 25. Local and distant control in non-metastatic pelvic Ewing's sarcoma patients.
    Donati D, Yin J, Di Bella C, Colangeli M, Bacci G, Ferrari S, Bertoni F, Barbieri E, Mercuri M.
    J Surg Oncol; 2007 Jul 01; 96(1):19-25. PubMed ID: 17345611
    [Abstract] [Full Text] [Related]

  • 26. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience.
    McLean TW, Hertel C, Young ML, Marcus K, Schizer MA, Gebhardt M, Weinstein HJ, Perez-Atayde A, Grier HE.
    J Pediatr Hematol Oncol; 1999 Jul 01; 21(6):486-93. PubMed ID: 10598659
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R, Stevens M.
    J Clin Oncol; 2004 Dec 01; 22(23):4787-94. PubMed ID: 15570080
    [Abstract] [Full Text] [Related]

  • 29. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
    Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M.
    Pediatr Blood Cancer; 2007 Aug 01; 49(2):196-8. PubMed ID: 17417796
    [Abstract] [Full Text] [Related]

  • 30. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.
    Atra A, Whelan JS, Calvagna V, Shankar AG, Ashley S, Shepherd V, Souhami RL, Pinkerton CR.
    Bone Marrow Transplant; 1997 Nov 01; 20(10):843-6. PubMed ID: 9404924
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH, Meyers PA.
    J Clin Oncol; 2001 Feb 01; 19(3):870-80. PubMed ID: 11157041
    [Abstract] [Full Text] [Related]

  • 33. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Krasin MJ, Davidoff AM, Rodriguez-Galindo C, Billups CA, Fuller CE, Neel MD, Merchant TE.
    Cancer; 2005 Jul 15; 104(2):367-73. PubMed ID: 15948159
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Salvage chemotherapy for recurrent Ewing's sarcomas.
    Ozaki T, Sugihara S, Hamada M, Nakagawa Y, Inoue H.
    Neoplasma; 1995 Jul 15; 42(1):39-42. PubMed ID: 7617074
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.